In addition, our in vitro results, both in hormone receptor-positive (representing Luminal A human breast cancer) and hormone receptor-negative (representing the triple-negative subtype) cells, suggest that HT and OLE are able to influence different breast cancer cell lines through estrogen receptor-independent pathways. The gene discussed is NR4A1; the disease is breast carcinoma.